Summary
Moody's Corporation (MCO) filed an 8-K on March 2, 2015, reporting on a significant financing event. On February 27, 2015, the company entered into an underwriting agreement to issue and sell €500 million of its 1.75% Senior Notes due 2027. This offering, facilitated by major underwriters including J.P. Morgan Securities plc, Merrill Lynch International, and The Royal Bank of Scotland plc, represents a strategic move by Moody's to secure long-term debt financing. The notes were registered under a previously filed Form S-3, indicating pre-existing authorization for such issuances. Investors should note this debt issuance as it impacts the company's capital structure and leverage.
Key Highlights
- 1Moody's Corporation entered into an underwriting agreement on February 27, 2015.
- 2The agreement is for the issuance and sale of €500 million in aggregate principal amount of Senior Notes.
- 3The Senior Notes will mature in 2027 and carry a coupon rate of 1.75%.
- 4Key underwriters for the offering include J.P. Morgan Securities plc, Merrill Lynch International, and The Royal Bank of Scotland plc.
- 5The offering was registered under Moody's existing Form S-3 (Registration No. 333-190259).
- 6The company also issued a press release on February 27, 2015, announcing the pricing of this note offering.
Frequently Asked Questions
The primary purpose of this 8-K filing was to report on Moody's Corporation's entry into an underwriting agreement for the issuance of €500 million of Senior Notes due 2027.
The Senior Notes have an aggregate principal amount of €500 million, a coupon rate of 1.75% per annum, and are due in 2027.
The underwriting agreement was entered into by Moody's Corporation and J.P. Morgan Securities plc, Merrill Lynch International, and The Royal Bank of Scotland plc, acting as representatives for the several underwriters.
This issuance increases Moody's total debt and impacts its capital structure. Investors should consider the increased leverage and the cost of this long-term financing when evaluating the company's financial health and future profitability.